Special Topic: Alzheimer's Disease> Top 20 Authors

Published March 2011

Authors | Institutions | Journals | Nations


Top 20 Authors

The authors on these lists have a heavy US bias, which, when one views the nation lists, is no surprise. The top authors also tend to correspond with the top institutions. For instance, Dennis Selkoe is the #1 author by total cites, and his institution, Harvard University, is #1 by cites (and by papers) among institutions. Selkoe is a strong proponent of the amyloid hypothesis of AD, and his research reflects this fact. In March of 2011, he spoke with us about his work.

Alzheimer's disease patient Carlos Alberto Henriques, 65, drinks water through a syringe in Lisbon, September 15, 2009. REUTERS/Nacho Doce.
Alzheimer's disease patient
Carlos Alberto Henriques, 65,
drinks water through a syringe
in Lisbon, September 15, 2009.
REUTERS/Nacho Doce.

Other notable US researchers in the top 20 include Virginia Lee and John Trojanowski, who together run the Center for Neurodegenerative Disease Research at the University of Pennsylvania, where their research in AD covers such topics as synucleinopathies, Lewy bodies, and biomarkers. The Mayo Clinic's Ronald Petersen has a great deal of highly cited papers relating to cognitive impairment and hippocampal neuropathology. George Perry of the University of Texas, San Antonio, and his frequent coauthor, the late Mark Smith of Case Western Reserve University, have published on oxidative stress, mitochondrial dysfunction, and tau phosphorylation. Mark Mattson of the NIA investigates signaling and metabolic issues in neurogenerative diseases, including AD.

Researchers from other nations making the top 20 include John Hardy of UCL, whose highly cited paper cover topics including amyloid deposition, beta peptide vaccination, and genomic screens for AD. Bengt Winblad of the Karolinska Institute focuses on cognitive impairment and risk factors for AD and other forms of dementia. Gothenburg University's Kaj Blennow has a great deal of highly cited papers on biomarkers, Philip Scheltens from VUMC in the Netherlands has published quite a few MRI studies of the AD brain. Colin Masters from the University of Melbourne looks at the interactions of metal ions, particularly copper and zinc, with amyloid beta.

 

Citations
   

Rank Author Citations Papers Cites per paper
1 Selkoe, DJ
SPECIAL TOPICS INTERVIEW
19,587 136 144.02
2 Lee, VMY
SPECIAL TOPICS INTERVIEW
13,693 217 63.10
3 Trojanowski, JQ
SPECIAL TOPICS INTERVIEW
13,237 239 55.38
4 Petersen, RC 11,875 220 53.98
5 Smith, MA
SPECIAL TOPICS TRIBUTE
11,807 329 35.89
6 Mattson, MP
SPECIAL TOPICS INTERVIEW
11,195 176 63.61
7 Perry, G
SPECIAL TOPICS INTERVIEW
11,180 292 38.29
8 Rogers, J 10,884 42 259.14
9 Hardy, J
SPECIAL TOPICS INTERVIEW
10,749 138 77.89
10 Winblad, B 10,146 292 34.75
11 Cummings, JL
SPECIAL TOPICS INTERVIEW
9,876 188 52.53
12 Bennett, DA
SPECIAL TOPICS INTERVIEW
9,577 209 45.82
13 Morris, JC
SPECIAL TOPICS INTERVIEW
9,323 203 45.93
14 Butterfield, DA 9,298 199 46.72
15 Hyman, BT 9,242 202 45.75
16 DeKosky, ST 9,067 184 49.28
17 Blennow, K 8,970 275 32.62
18 Rosenthal, A 8,777 8 1097.13
19 Masliah, E 8,413 186 45.23
20 Deloukas, P 8,097 5 1619.40

Papers
   

Rank Author Citations Papers Cites per paper
1 Smith, MA
SPECIAL TOPICS TRIBUTE
11,807 329 35.89
2 Perry, G
SPECIAL TOPICS INTERVIEW
11,180 292 38.29
3 Winblad, B 10,146 292 34.75
4 Blennow, K 8,970 275 32.62
5 Scheltens, P 6,421 244 26.32
6 Trojanowski, JQ
SPECIAL TOPICS INTERVIEW
13,237 239 55.38
7 Petersen, RC 11,875 220 53.98
8 Lee, VMY
SPECIAL TOPICS INTERVIEW
13,693 217 63.10
9 Bennett, DA
SPECIAL TOPICS INTERVIEW
9,577 209 45.82
10 Morris, JC
SPECIAL TOPICS INTERVIEW
9,323 203 45.93
11 Hyman, BT 9,242 202 45.75
12 Masters, CL
SPECIAL TOPICS INTERVIEW
7,507 200 37.54
13 Butterfield, DA 9,298 199 46.72
14 Miller, BL 6,466 195 33.16
15 Cummings, JL
SPECIAL TOPICS INTERVIEW
9,876 188 52.53
16 Masliah, E 8,413 186 45.23
17 DeKosky, ST 9,067 184 49.28
18 Mattson, MP
SPECIAL TOPICS INTERVIEW
11,195 176 63.61
19 Soininen, H 5,478 176 31.13
20 Hodges, JR 7,209 170 42.41

Cites Per Paper (>= 27 paper threshold)
   

Rank Author Citations Papers Cites per paper
1 Rogers, J 10,884 42 259.14
2 Selkoe, DJ
SPECIAL TOPICS INTERVIEW
19,587 136 144.02
3 Ashe, KH 4,706 37 127.19
4 Tycko, R 3,476 28 124.14
5 Walsh, DM 5,909 48 123.10
6 Greengard, P 4,382 38 115.32
7 Kayed, R 4,513 41 110.07
8 Finch, CE 3,832 36 106.44
9 Mallory, M 3,079 30 102.63
10 Seshadri, S 3,205 33 97.12
11 Schmidt, AM 2,672 28 95.43
12 Hong, JS 2,939 32 91.84
13 McGowan, E 2,917 32 91.16
14 Stefani, M 2,643 29 91.14
15 Dobson, CM 6,373 70 91.04
16 Wyss-Coray, T 3,494 39 89.59
17 Griffin, WST 3,242 37 87.62
18 Meijer, L 2,522 29 86.97
19 Tangalos, EG 3,042 35 86.91
20 Eckman, CB 2,366 28 84.50

About The Authors



The resulting database contained 125,258 authors. Ranked by three separate measures: citations, papers, and citations per paper. Source dates: January 1, 2000-December 31, 2010. *Unless otherwise specified, all rankings have a >= 5 paper threshold for all measures.

Look for complelte threshold information for the Special Topic of Alzheimer's Disease in the "Methodology & Threshold" tab of the opening page for this topic.

Overall General Information


 
Regarding Top 20 Scientists, Institutions, Journals, & Nations

Citation tables allow us to map compelling trends:

  • Are there particular nations or institutions that might be expected to dominate research in the Topic area, and do the numbers bear out these expectations, or are there surprises?
  • Who are the leading scientists and where are they located?

While these tables cannot offer a complete picture, the number of trends and anomalies that can be spotlighted or connected across categories is striking. The tables often lead to renewed perspectives to further explore and validate.

What are Special Topics?



Special Topics, from ScienceWatch.com, is designed to complement Essential Science IndicatorsSM from Thomson Reuters in providing citation analyses and commentary for selected scientific research areas that have experienced notable recent advances or are of special current interest.

Read about the overall methodology for Special Topics in the "What are Special Topics?" page.

 

   |   BACK TO TOP


Alzheimer's Disease

 HOME PAGE OF TOPIC

SPECIAL TOPICS